The developed immunoassay method showed good selectivity and acceptable reproducibility.
Progesterone levels determined by the proposed electrochemical immunoassay compared favourably with a colorimetric immunoassay method.
The proposed new immunoassay method has potential applications in proteomics research and clinical diagnosis.
To determine whether levels of antimüllerian hormone (AMH) in serum vary during the normal menstrual cycle, using the most recently developed immunoassay method.
Due to the simple preparation of the nanoprobe and the low cost, convenient operation of the detection strategy, this nonenzymatic immunoassay method possesses great potentials for practical applications.
Clinical serum specimens were assayed with the method, and the results were received in good accordance with those obtained from the referenced electrochemiluminescent immunoassay method.
This immunoassay method would open up a new promising platform to detect various tumor markers at ultralow levels for early diagnoses of different cancers.
We describe the analytical and clinical validation of an automated, antibody- and microparticle-based, chemiluminescent immunoassay method for the determination of 25 OH vitamin D.
By combining with a disposable protein array, an ultrasensitive and high-throughput multiplex CL immunoassay method was proposed for simultaneous detection of four cancer biomarkers.
Furthermore, the immunoassay method was evaluated using human serum samples, and the recovery obtained was within 99.0 and 102.7%, indicating that the immunosensor has potential clinical applications.
An ultrasensitive multiplexed electrochemical immunoassay method was developed for the detection of tumor markers by combining a newly designed trace tag and a disposable immunosensor array.
